Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Greenbelt, Maryland Clinical Trials

A listing of Greenbelt, Maryland clinical trials actively recruiting patient volunteers.

RESULTS

Found (15) clinical trials

The primary objective is to evaluate the efficacy of fasinumab compared with placebo, when administered for up to 16 weeks in patients with pain due to OA of the knee or hip.  

Phase

9.39 miles

Learn More »

The total duration of the study is up to 182 weeks, consisting of 3 study periods: a ≤6-week screening period, a 52-week double-blind period, and a 124-week extension period.  

Phase N/A

9.39 miles

Learn More »

A Randomized, Active-Controlled, Double-Blind Study Comparing ABT-494 To Abatacept In Subjects With Moderately To Severely Active Rheumatoid Arthritis With Inadequate Response Or Intolerance To Biologic Dmards (Bdmards) On Stable Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs (Csdmards).  

Phase

9.39 miles

Learn More »

A Randomized, Double Blinded, Parallel Group, Placebo And Active Controlled, Multicenter Phase III Study Of The Efficacy And Safety Of Olokizumab In Subjects With Moderately To Severely Active Rheumatoid Arthritis Inadequately Controlled By Methotrexate Therapy.  

Phase

9.39 miles

Learn More »

A Placebo-Controlled Randomized Trial Of Stopping Anti-TNF Agents (Etanercept, Adalimumab Or Infliximab) In Patients With Rheumatoid Arthritis (RA) Who Are In Sustained Remission.  

Phase N/A

9.39 miles

Learn More »

Treatments Against RA and Effect on FDG PET-CT  

Phase N/A

9.39 miles

Learn More »

Randomized, Double-Blind, Parallel-Group, Multi-center study of secukinumab to compare 300 mg and 150 mg at Week 52 in patients with AS who are randomized to dose escalation after not achieving inactive disease during an initial 16 weeks of open-label tx w/secukinumab 150 mg (ASLeap)  

Phase

9.39 miles

Learn More »